These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 170516)

  • 1. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
    Furukawa Y; Sohn H; Unakami H; Yumita S
    Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat.
    Armbrecht HJ; Zenser TV; Davis BB
    J Clin Invest; 1980 Nov; 66(5):1118-23. PubMed ID: 6893596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
    Wright DR
    N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC; Young RB; Hartenberg MA; Chinchilli VM
    J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolism.
    Holick MF; DeLuca HF
    Annu Rev Med; 1974; 25():349-67. PubMed ID: 4363209
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
    Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
    Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoparathyroidism during pregnancy: treatment with calcitriol.
    Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
    Kind HP; Prader A; DeLuca HF; Gugler E
    Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
    [No Abstract]   [Full Text] [Related]  

  • 20. Current therapy of hypoparathyroidism--a survey of German endocrinology centers.
    Schilling T; Ziegler R
    Exp Clin Endocrinol Diabetes; 1997; 105(4):237-41. PubMed ID: 9285213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.